Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer
Background: The protease-activated receptor 1 (PAR1) is associated with increased invasiveness of breast cancer (BC) cell lines and its overexpression is significantly correlated with advanced stage and poor prognosis. The aim of this study was to determine the clinical significance of the serum PAR...
Main Authors: | Rumeysa Ciftci, Faruk Tas, Elif Bilgin, Serkan Keskin, Ibrahim Yildiz, Derya Duranyildiz, Pınar Saip, Hasan Karanlik, Sezai Vatansever |
---|---|
Format: | Article |
Language: | English |
Published: |
Turkiye Klinikleri
2016-04-01
|
Series: | Journal of Oncological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452336416300206 |
Similar Items
-
Serum vascular cell adhesion molecule-1 (VCAM1) level is elevated in colorectal cancer regardless of the tumor stage
by: Rumeysa Ciftci, et al.
Published: (2016-06-01) -
Clinical Significance of Serum Membrane-Bound Mucin-2 Levels in Breast Cancer
by: Suleyman Bademler, et al.
Published: (2019-01-01) -
Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer
by: Cigdem Usul Afsar, et al.
Published: (2018-12-01) -
Complement factor C4a does not activate protease‐activated receptor 1 (PAR1) or PAR4 on human platelets
by: Xu Han, et al.
Published: (2021-01-01) -
The Cysteine Protease MaOC1, a Prokaryotic Caspase Homolog, Cleaves the Antitoxin of a Type II Toxin-Antitoxin System
by: Marina Klemenčič, et al.
Published: (2021-02-01)